Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs MasTec Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while MasTec Inc trades at $190.11 (market cap $15.62B). The key difference: MasTec Inc is far larger — about 2.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Ionis Pharmaceuticals Inc. Common Stock is more actively traded (2,027,457 versus 1,770,191). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and MasTec Inc for 25 Days on average.
| IONS | MTZ | |
|---|---|---|
Market Cap | $7.10B | $15.62B |
Volume | 2,027,457 | 1,770,191 |
Sector | Health | Industrials |
52-Week High | $86.50 | $437.51 |
52-Week Low | $42.38 | $190.08 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $6.66B | $18.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MasTec (MTZ) trades at $206.12, down 0.35% on the day, with a bearish technical signal despite strong analyst support. The stock shows mixed fundamentals with a P/E of 30.96 and P/S of 0.95, while recent earnings beat expectations in two of the last three quarters. The company benefits from record backlog growth and infrastructure investment cycles, particularly in power delivery and data center markets, though cash flow trends show volatility between periods.
The outlook remains positive with 89% analyst buy ratings and a $403.92 consensus price target suggesting significant upside potential. Key risks include premium valuation concerns, communications segment softness, and execution challenges in managing rapid backlog growth. Infrastructure demand drivers provide strong tailwinds, but investors should monitor cash flow improvement and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
